AEHR TEST SYSTEMS WKN: 908802 ISIN: US00760J1088 Forum: Aktien Thema: Hauptdiskussion
Kopier ma paar Aussagen aus einer Gruppe Fox xp ai chip orders are coming soon. Mark my words. AEHR could still 3x from here. Not that I recommend chasing but I am sure there will be dip buying opportunities. By the way. I just want to remind the room. I told all of you several times to look at AEHR last April in the 7s. And of course to this day I keep beating the drum. I do have one 3rd party expert who is bearish on AEHR. So they do not all say what I want to hear. He says AEHR is lagging behind where they should be due to ceo still thinking too small. And our last interview with Gayn last week, he’s got his capacity built up and he’s ready to go if the big orders come in. So I think he’s not necessarily thinking too small. So if we get north of $70 I might be less enthused. But until then I am still quite engaged and bullish. The other thing I am thinking. Somebody will buy AEHR if they keep winning deals. DYOR
|
|
Thema | ||
|---|---|---|---|
| 1 | DAX / Germany 40 Hauptdiskussion | +0,31 % | |
| 2 | VONOVIA Hauptdiskussion | +0,25 % | |
| 3 | Metaplanet | +20,45 % | |
| 4 | Strategy B | +9,45 % | |
| 5 | BTC/USD Hauptdiskussion | +6,19 % | |
| 6 | DAX Prognose / Germany 40 | +0,31 % | |
| 7 | für alle, die es ehrlich meinen beim Traden. | ||
| 8 | APOLLO MINERALS Hauptdiskussion | +11,59 % | |
| 9 | Circus SE Inhaber-Akt Hauptdiskussion | +7,36 % | |
| 10 | Linien und Wellen Austausch Forum | +9,45 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | VONOVIA Hauptdiskussion | +0,22 % | |
| 2 | Metaplanet | +21,11 % | |
| 3 | Strategy B | +9,99 % | |
| 4 | Circus SE Inhaber-Akt Hauptdiskussion | +7,36 % | |
| 5 | APOLLO MINERALS Hauptdiskussion | +11,59 % | |
| 6 | Linien und Wellen Austausch Forum | +9,99 % | |
| 7 | Novo Nordisk nach Split | -0,18 % | |
| 8 | MODERNA INC. DL-,0001 Hauptdiskussion | +1,29 % | |
| 9 | ATOS Hauptdiskussion | -0,24 % | |
| 10 | RHEINMETALL Hauptdiskussion | -1,27 % | Alle Diskussionen |